<DOC>
	<DOCNO>NCT00178607</DOCNO>
	<brief_summary>To correlate Human Leukocyte Antigen type genetic defect hemophilia A .</brief_summary>
	<brief_title>Covalent Tolerance Induction Factor VIII-Prediction Inhibitors Hemophilia</brief_title>
	<detailed_description>One serious complication treatment patient hemophilia A hemophilia B development inhibitor , antibody neutralizes factor VIII IX coagulant activity . Up one fourth patient severe hemophilia A develop inhibitor present possible predict patient develop antibody . The ability predict inhibitor development individual level would greatly improve therapeutic approach serious problem</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Severe Hemophilia A inhibitor level 0.6 B.U . high Severe Hemophilia A negative inhibitor</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Inhibitors</keyword>
</DOC>